Publications by authors named "Amy D Shapiro"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

29,313

Total Likes

995

Extended Reach

3,350,215

Social Features

72
G
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Adam Cuker, Kaan Kavakli, Laurent Frenzel, Jiaan-Der Wang, Jan Astermark, Monica H Cerqueira, Alfonso Iorio, Olga Katsarou-Fasouli, Robert Klamroth, Amy D Shapiro

N Engl J Med· September 2024

Videos about Article: user user

2 3 46 6 72

View All Article and Social Media Activity
A
A null mutation in protects against biological aging in humans.
Sadiya S Khan, Sanjiv J Shah, Ekaterina Klyachko, Abigail S Baldridge, Mesut Eren, Aaron T Place, Abraham Aviv, Eli Puterman, Donald M Lloyd-Jones, Meadow Heiman

November 2017

Videos about Article: user user

2 22 3 11 1

View All Article and Social Media Activity
E
Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study.
Jan Astermark, Petra LeBeau, Anders Christensson, Stefan Lethagen, Erik Berntorp, Amy D Shapiro

Res Pract Thromb Haemost· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis/thromboembolism.
Yaqiu Sang, Marzia Menegatti, Jennifer A Brody, Kerri L Wiggins, Brian C Cooley, Amy D Shapiro

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I treat type 1 plasminogen deficiency.
Amy D Shapiro, Charles Nakar

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Long-Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy.
Amy D Shapiro, Heather McDaniel, Robert W Decker, Charles Nakar, Jeremy Lorber

Haemophilia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding.
Magdalena D Lewandowska, Shelby Gordon, Anthony Betbadal, Amy D Shapiro

J Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Therapies in Hemophilia: Improving Equitable Access to Care.
Magdalena Lewandowska, Sonia Nasr, Amy D Shapiro

J Blood Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired factor V inhibitor in a case of pediatric venous thrombosis.
Sweta Gupta, Matthew W Bunce, Emily A Cid, Rodney M Camire, Amy D Shapiro

Res Pract Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor VIIa: new insights into the mechanism of action through product innovation.
Miguel A Escobar, Maureane Hoffman, Giancarlo Castaman, Cedric Hermans, Johnny Mahlangu, Amy D Shapiro

Res Pract Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1.
Charles Nakar, Heather McDaniel, Joseph M Parker, Karen Thibaudeau, Neelam Thukral, Amy D Shapiro

Front Pediatr· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor IX Fc for the treatment of hemophilia B.
Rolf Ljung, Davide Matino, Amy D Shapiro

Eur J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasminogen, human-tvmh for the treatment of children and adults with plasminogen deficiency type 1.
Amy D Shapiro, Charles Nakar, Joseph M Parker, Karen Thibaudeau, Roberto Crea

Haemophilia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study.
Omotola O Olasupo, Charles Nakar, Craig Haddix, Thushara Matthew, Davide Matino, Amy D Shapiro

Res Pract Thromb Haemost· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytes.
Wen Dai, Heng Zhang, Hayley Lund, Ziyu Zhang, Mark Castleberry, Amy D Shapiro

Science· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis.
Amy D Shapiro, Hervé Chambost, Margareth C Ozelo, Aletta Falk, Helena Ahlin

Res Pract Thromb Haemost· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand.
María-Teresa Álvarez-Román, Amy D Shapiro, Margaret V Ragni, Helena Palmborg, Linda Bystrická

Res Pract Thromb Haemost· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.
Amy D Shapiro, Roshni Kulkarni, Margaret V Ragni, Hervé Chambost, Johnny Mahlangu

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe FVII deficiency presenting with heterotopic gastric mucosa: hoofbeats may be a zebra.
Sweta Gupta, Amy D Shapiro, Eric E Tibesar

Haemophilia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.
Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Amy D Shapiro

Lancet Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.
Diane Nugent, Suchitra S Acharya, Kimberly J Baumann, Camille Bedrosian, Rebecca Bialas, Amy D Shapiro

Expert Rev Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review.
Amy D Shapiro, Brandon M Hardesty, Flora Peyvandi, Alfonso Iorio

Res Pract Thromb Haemost· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Ligneous Conjunctivitis with Plasminogen Eyedrops.
Roberto Caputo, Amy D Shapiro, Maria Teresa Sartori, Andrea Leonardi, Bennie H Jeng

Ophthalmology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Steven W Pipe, Cédric Hermans, Meera Chitlur, Manuel Carcao, Giancarlo Castaman, Amy D Shapiro

Haemophilia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic and technological advancements in haemophilia care: Quantum leaps forward.
Magdalena Lewandowska, Sonia Nasr, Amy D Shapiro

Haemophilia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis